DOI QR코드

DOI QR Code

Induction of the Neutrophil Migration in Normal Subjects due to Asthmatic Bronchoalveolar Lavage Fluid (BALF)

  • Lee, Ji-Sook (Department of Clinical Laboratory Science, Wonkwang Health Science University) ;
  • Choi, Eugene (Department of Respiratory Internal Medicine, College of Medicine, Konyang University) ;
  • Yang, Eun Ju (Department of Clinical Laboratory Science, Daegu Haany University) ;
  • Lee, Na Rae (Department of Biomedical Laboratory Science, School of Medicine, Eulji University) ;
  • Baek, Seung Yeop (Department of Senior Healthcare, BK21 Plus Program, Graduated School, Eulji University) ;
  • Kim, Eun Jeong (Department of Senior Healthcare, BK21 Plus Program, Graduated School, Eulji University) ;
  • Kim, In Sik (Department of Biomedical Laboratory Science, School of Medicine, Eulji University)
  • Received : 2014.03.09
  • Accepted : 2014.03.24
  • Published : 2014.09.30

Abstract

Human neutrophils play an essential role in the innate immune response and are involved in the pathogenesis of the severe and corticosteroid-resistant asthma. Asthma is characterized by an infiltration of inflammatory cells into the lung and by a cytokine release. The aim of this study is to investigate the effects of a bronchoalveolar lavage fluid (BALF) on the chemotaxis and apoptosis of neutrophils which were isolated from healthy subjects. The BALF of subjects with asthma induces the blood neutrophil chemotaxis in the opposite of that in normal subjects. The IL-8, IL-6, and monocyte chemoattractant protein-1 (MCP-1) levels in BALF were higher in subjects with asthma than in normal subjects. The BALF of normal and asthmatic subjects has no effect on neutrophil apoptosis of BALF. MCP-1 delays the constitutive apoptosis of normal blood neutrophils, but has no effect in normal BALF neutrophils. These results may indicate that inflammatory factors secreted by the lung tissue of patients with asthma trigger the neutrophil chemotaxis and also induce the neutrophil dysregulation.

Keywords

References

  1. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol. 1997. 15: 675-705. https://doi.org/10.1146/annurev.immunol.15.1.675
  2. Choi E, Yang EJ, Kim DH, Lee JS, Kim IS. CCR expression of bronchoalveolar lavage fluid (BALF) neutrophils and chemotactic activity of BALF. J Exp Biomed Sci. 2011. 17: 89-93.
  3. Douwes J, Gibson P, Pekkanen J, Pearce N. Non-eosinophilic asthna: Importance and possible mechanisms. Thorax. 2002. 57: 643-648. https://doi.org/10.1136/thorax.57.7.643
  4. Fahy JV, Kim W, Liu J, Boushey HA. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol. 1995. 95: 843-852. https://doi.org/10.1016/S0091-6749(95)70128-1
  5. Fireman P. Understanding asthma pathophysiology. Allergy and Asthma Proceedings. 2003. 24: 79-83.
  6. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med. 1999. 160: 1532-1539. https://doi.org/10.1164/ajrccm.160.5.9806170
  7. Kim IS, Kim EH, Kim DH, Kim JS, Lee JS. Effect of house dust mite and CCL2 on S100A8 and S100A9 expression in human monocytes. Biomed Sci Lett. 19: 344-377.
  8. Lacoste JY, Bousquet J, Chanez P, Van Vyve T, Simony-Lafontaine J, Lequeu N, Vic P, Enander I, Godard P, Michel FB. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 1993. 92: 537-548. https://doi.org/10.1016/0091-6749(93)90078-T
  9. Murdoch C, Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood. 2000. 95: 3032-3043.
  10. Murphy PM, Baggiolini M, Charo IF, Hebert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ, Power CA. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev. 2000. 52: 145-176.
  11. Ordonez CL, Shaughnessy TE, Matthay MA, Fahy JV. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma. Am J Respir Crit Care Med. 2000. 161: 1185-1190. https://doi.org/10.1164/ajrccm.161.4.9812061
  12. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophage. J Clin Invest. 1989. 83: 865-875. https://doi.org/10.1172/JCI113970
  13. Schenkel E, Atkins PC, Yost R, Zweiman B. Antigen-induced neutrophil chemotactic activity from sensitized lung. J Allergy Clin Immunol. 1982. 70: 321-325. https://doi.org/10.1016/0091-6749(82)90020-3
  14. Simon HU. Neutrophil apoptosis pathways and their modifications in inflammation. Immunol Rev. 2003. 193: 101-110. https://doi.org/10.1034/j.1600-065X.2003.00038.x
  15. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L. Neutrophils: Molecules, functions and pathophysiological aspects. Lab Invest. 2000. 80: 617-653. https://doi.org/10.1038/labinvest.3780067
  16. Yang EJ, Choi EG, Ko JS, Kim D-H, Lee J-S, Kim IS. Differential Effect of CCL2 on Constitutive Neutrophil apoptosis between normal and asthmatic subjects. J Cell Physiol. 2012. 227: 2567-2577. https://doi.org/10.1002/jcp.22995
  17. Zhang JY, Wenzel SE. Tissue and BAL based biomarkers in asthma. Immunol Allergy Clin North Am. 2007. 27: 623-632. https://doi.org/10.1016/j.iac.2007.09.003